Does LUBIPROSTONE Cause Interstitial lung disease? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with LUBIPROSTONE (Amitza). This represents 0.4% of all adverse event reports for LUBIPROSTONE.
5
Reports of Interstitial lung disease with LUBIPROSTONE
0.4%
of all LUBIPROSTONE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From LUBIPROSTONE?
Of the 5 reports, 4 (80.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUBIPROSTONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LUBIPROSTONE Cause?
Diarrhoea (170)
Drug ineffective (131)
Nausea (110)
Constipation (82)
Vomiting (75)
Dizziness (59)
Abdominal distension (57)
Dyspnoea (53)
Headache (47)
Abdominal pain (45)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LUBIPROSTONE Alternatives Have Lower Interstitial lung disease Risk?
LUBIPROSTONE vs LUCENTIS
LUBIPROSTONE vs LUCRIN DEPOT
LUBIPROSTONE vs LUMASIRAN
LUBIPROSTONE vs LUMATEPERONE
LUBIPROSTONE vs LUMIGAN